Detalhe da pesquisa
1.
Trastuzumab beyond progression for HER2 positive metastatic breast cancer: progression-free survival on first-line therapy predicts overall survival impact.
Breast J
; 20(4): 408-13, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24985529
2.
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
Lancet Oncol
; 14(1): 72-80, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23246022
3.
The association of healthcare contact days with physical function and survival in CCTG/AGITG CO.17.
J Natl Cancer Inst
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38656931
4.
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in Canada.
Clin Colorectal Cancer
; 23(1): 46-57.e4, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007297
5.
Impact of the COVID-19 Pandemic on Medical Oncology Workload: A Provincial Review.
Curr Oncol
; 30(3): 3149-3159, 2023 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975451
6.
Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial.
JCO Oncol Pract
; 19(6): e859-e866, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881786
7.
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 6(12): e2346094, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38051531
8.
Gastrointestinal stromal tumors caused by novel germline variants in SDHB and KIT: a report of two cases and literature review.
Clin J Gastroenterol
; 15(5): 869-875, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35821557
9.
Abstracts of the 2022 Canadian Association of Medical Oncologists Annual Scientific Meeting.
Curr Oncol
; 29(6): 3962-3982, 2022 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35735426
10.
Abstracts of the 2021 Canadian Association of Medical Oncologists Annual Meeting.
Curr Oncol
; 28(3): 2199-2226, 2021 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203593
11.
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.
Curr Oncol
; 28(3): 1988-2006, 2021 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34073199
12.
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study.
JAMA Oncol
; 6(6): 831-838, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32379280
13.
Adjuvant docetaxel for node-positive breast cancer.
N Engl J Med
; 352(22): 2302-13, 2005 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-15930421
14.
Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer.
J Clin Oncol
; 20(4): 987-93, 2002 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11844821
15.
Randomized, open-label, phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer.
J Clin Oncol
; 20(6): 1519-26, 2002 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11896100
16.
Navigating later lines of treatment for advanced colorectal cancer - optimizing targeted biological therapies to improve outcomes.
Cancer Treat Rev
; 40(10): 1171-81, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25458604
17.
Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
J Natl Cancer Inst
; 101(17): 1182-92, 2009 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19666851